Oral Fluconazole Dosing for Candidiasis
For most candidal infections, oral fluconazole 200-400 mg (3-6 mg/kg) daily is the recommended dose, with specific adjustments based on infection site, severity, and renal function.
Dosing by Infection Type
Oropharyngeal Candidiasis
- Mild disease: Topical agents preferred (clotrimazole troches 10 mg 5 times daily for 7-14 days) 1
- Moderate to severe disease: Fluconazole 100-200 mg daily for 7-14 days 1
- Loading dose approach: 200 mg on day 1, then 100 mg daily for at least 2 weeks 2
Esophageal Candidiasis
- Standard dosing: Fluconazole 200-400 mg (3-6 mg/kg) daily for 14-21 days 1
- Loading dose approach: 200 mg on day 1, then 100 mg daily, with doses up to 400 mg/day based on response 2
- Minimum duration: 3 weeks and at least 2 weeks after symptom resolution 1
Urinary Tract Candidiasis
Cystitis (fluconazole-susceptible organisms):
- Fluconazole 200 mg (3 mg/kg) daily for 2 weeks 1
Pyelonephritis:
- Fluconazole 200-400 mg (3-6 mg/kg) daily for 2 weeks 1
Important caveat: Treatment is NOT recommended for asymptomatic candiduria unless the patient is neutropenic, very low birth weight (<1500g), or undergoing urologic procedures 1
Vaginal Candidiasis
- Single dose: Fluconazole 150 mg as a one-time oral dose 2
Renal Dose Adjustments
Fluconazole is primarily renally eliminated (60% unchanged in urine), making dose adjustment critical in renal impairment 2, 3.
Standard Adjustment Protocol 2
- Give full loading dose (50-400 mg based on indication) regardless of renal function
- Adjust maintenance dose based on creatinine clearance:
| Creatinine Clearance | Dose Adjustment |
|---|---|
| >50 mL/min | 100% of standard dose |
| ≤50 mL/min (no dialysis) | 50% of standard dose |
| Hemodialysis | 100% after each dialysis session |
Calculating Creatinine Clearance
Males: [Weight (kg) × (140 - age)] / [72 × serum creatinine (mg/dL)]
Females: 0.85 × male calculation 2
Continuous Renal Replacement Therapy (CRRT)
The evidence shows significant variability in fluconazole elimination during CRRT, with higher doses required to achieve therapeutic targets:
- CVVH (ultrafiltrate 0.5 L/h): Multiply anuric dose × 2.2 4
- CVVHD (dialysate/ultrafiltrate 1.5 L/h): Multiply anuric dose × 3.8 4
- Recent data for CVVHD: At least 400 mg twice daily achieves target attainment in 100% of critically ill patients 5
Critical point: CVVHD clearance of fluconazole can exceed that of healthy individuals, with clearance rates around 2 L/h 4. The most recent high-quality study demonstrates that 400 mg twice daily is necessary for critically ill patients on CVVHD 5, which is substantially higher than older recommendations.
Prolonged Intermittent Renal Replacement Therapy (PIRRT)
Monte Carlo simulations suggest 800 mg loading dose plus 400 mg twice daily (pre and post PIRRT) achieves therapeutic targets in 93-96% of patients 6.
Hemodialysis Specifics
- Approximately 38% of a 50 mg dose is removed during a 3-hour hemodialysis session 7
- Half-life extends to approximately 3 times normal in severe renal impairment (GFR <20 mL/min) 7
- Administer 100% of recommended dose after each dialysis session 2
Key Clinical Considerations
Loading Dose Strategy
Always use a loading dose equal to twice the maintenance dose on day 1 to achieve steady-state concentrations rapidly 2. This is particularly important given fluconazole's long half-life (31-37 hours), which requires 6 days to reach steady-state without loading 3.
Species-Specific Resistance
- C. glabrata: Often fluconazole-resistant; use amphotericin B or flucytosine 1
- C. krusei: Intrinsically fluconazole-resistant; use amphotericin B 1
- C. lusitaniae: MIC values often above epidemiologic cutoff (4-16 μg/mL) 8
Therapeutic Drug Monitoring
Drug monitoring is recommended in life-threatening infections, especially during CRRT, despite fluconazole's broad therapeutic margin 4. Target AUC24h:MIC ratio of 100 for optimal outcomes 6.
Common Pitfalls
- Forgetting the loading dose: Results in subtherapeutic levels for nearly a week
- Not adjusting for renal function: Fluconazole accumulates significantly with impaired clearance
- Underdosing in CRRT: Older recommendations (200 mg daily) are insufficient; use at least 400 mg twice daily 5
- Treating asymptomatic candiduria: Unnecessary unless high-risk patient 1
- Inadequate treatment duration: Minimum 2 weeks for most infections, 3 weeks for esophageal disease 1